Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution

Tyrosine Kinase ◽

Retrospective Analysis ◽

Real World ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Single Institution ◽

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

Journal of Hematology & Oncology ◽

10.1186/s13045-018-0686-1 ◽

2019 ◽

Vol 12 (1) ◽

Cited By ~ 24

Author(s):

Kamal Chamoun ◽

Hagop Kantarjian ◽

Rami Atallah ◽

Graciela Nogueras Gonzalez ◽

Ghayas C. Issa ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Single Institution ◽

Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience

Hematological Oncology ◽

10.1002/hon.2896 ◽

2021 ◽

Author(s):

Hiroshi Ureshino ◽

Kazuharu Kamachi ◽

Atsujiro Nishioka ◽

Sho Okamoto ◽

Hiroo Katsuya ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Budget Impact of Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia With Sustained Deep Molecular Response

Value in Health ◽

10.1016/j.jval.2020.11.010 ◽

2021 ◽

Author(s):

Cyril Astrugue ◽

Antoine Bénard ◽

Pauline Bosco-Levy ◽

Stéphanie Dulucq ◽

Magali Rouyer ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Budget Impact ◽

Kinase Inhibitor ◽

Molecular Response ◽

Deep Molecular Response ◽

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.12.019 ◽

2020 ◽

Vol 20 (5) ◽

pp. 267-271 ◽

Cited By ~ 2

Author(s):

Anna Petrova ◽

Ekaterina Chelysheva ◽

Oleg Shukhov ◽

Anastasiya Bykova ◽

Irina Nemchenko ◽

...

Keyword(s):

Tyrosine Kinase ◽

Prospective Study ◽

Withdrawal Syndrome ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story

Pediatric Hematology and Oncology ◽

10.1080/08880018.2020.1751755 ◽

2020 ◽

Vol 37 (5) ◽

pp. 375-379 ◽

Cited By ~ 1

Author(s):

Lisa Triche ◽

Angela Yarbrough ◽

Michael Roth ◽

Anita Ying ◽

Robert Wells

Keyword(s):

Tyrosine Kinase ◽

Short Story ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Molecular Response ◽

Failed Attempt ◽

Increased values of the circulating PDGFβ sustains the “withdrawal syndrome” after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia

Blood Cells Molecules and Diseases ◽

10.1016/j.bcmd.2015.06.010 ◽

2015 ◽

Vol 55 (3) ◽

pp. 211-212 ◽

Cited By ~ 2

Author(s):

Sara Galimberti ◽

Giulia Fontanelli ◽

Sara Barsotti ◽

Federica Ricci ◽

Francesca Guerrini ◽

...

Keyword(s):

Tyrosine Kinase ◽

Withdrawal Syndrome ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

World Journal of Clinical Oncology ◽

10.5306/wjco.v11.i12.996 ◽

2020 ◽

Vol 11 (12) ◽

pp. 996-1007

Author(s):

Ruth Stuckey ◽

Juan Francisco López-Rodríguez ◽

Santiago Sánchez-Sosa ◽

Adrián Segura-Díaz ◽

Nuria Sánchez-Farías ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Discontinuation ◽

Predictive Indicators

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

Cancer Medicine ◽

10.1002/cam4.3071 ◽

2020 ◽

Vol 9 (12) ◽

pp. 4160-4165 ◽

Cited By ~ 4

Author(s):

Massimo Breccia ◽

Pier Paolo Olimpieri ◽

Odoardo Olimpieri ◽

Fabrizio Pane ◽

Alessandra Iurlo ◽

...

Keyword(s):

Tyrosine Kinase ◽

Retrospective Analysis ◽

Myeloid Leukemia ◽

Second Generation ◽

Kinase Inhibitor ◽

Line Treatment ◽

Second Line

Chronic Myeloid Leukemia—the Promise of Tyrosine Kinase Inhibitor Discontinuation

Current Hematologic Malignancy Reports ◽

10.1007/s11899-017-0404-z ◽

2017 ◽

Vol 12 (5) ◽

pp. 415-423 ◽

Cited By ~ 3

Author(s):

Ravi Kishore Narra ◽

Kathryn E. Flynn ◽

Ehab Atallah

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Profiles of NK cell subsets are associated with successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia and changes following interferon treatment

Annals of Hematology ◽

10.1007/s00277-021-04606-9 ◽

2021 ◽

Author(s):

Jun Kong ◽

Ya-zhen Qin ◽

Xiao-Su Zhao ◽

Yue Hou ◽

Kai-yan Liu ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Nk Cell ◽

Interferon Treatment ◽